The growing interest in peptides has resulted a considerable grey industry, presenting substantial risks to users. These kinds of materials are frequently manufactured beyond strict regulatory oversight, suggesting such purity and potency can be highly inconsistent. In addition, the vendors may lack accurate details regarding materials, potential s